Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer

Brandon M. Bordeau; Daniel A. Ciulla; Brian P. Callahan

doi:10.1002/cmdc.201600238

Hedgehog Proteins Consume Steroidal CYP17A1 Antagonists: Potential Therapeutic Significance in Advanced Prostate Cancer

ChemMedChem ◽

10.1002/cmdc.201600238 ◽

2016 ◽

Vol 11 (18) ◽

pp. 1983-1986 ◽

Cited By ~ 7

Author(s):

Brandon M. Bordeau ◽

Daniel A. Ciulla ◽

Brian P. Callahan

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Hedgehog Proteins

Download Full-text

599: A Large Proportion of Patients with Advanced Prostate Cancer Continue to Die of Non-Cancer Causes After 5 Years Follow-Up

The Journal of Urology ◽

10.1016/s0022-5347(18)30839-5 ◽

2007 ◽

Vol 177 (4S) ◽

pp. 200-201

Author(s):

Vivek K. Wadhwa ◽

Robin Weston ◽

Nigel J. Parr

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer

Download Full-text

Hormonal Drug Degarelix Approved For Treating Advanced Prostate Cancer

Internal Medicine News ◽

10.1016/s1097-8690(09)70046-0 ◽

2009 ◽

Vol 42 (2) ◽

pp. 4

Author(s):

BETSY BATES

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer

Download Full-text

Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: Preliminary results

Seminars in Oncology ◽

10.1053/sonc.2001.26895 ◽

2001 ◽

Vol 28 (4M) ◽

pp. 22-31 ◽

Cited By ~ 1

Author(s):

Arif Hussain ◽

Nancy Dawson ◽

Pradip Amin ◽

Michael Naslund ◽

Christine Engstrom ◽

...

Keyword(s):

Prostate Cancer ◽

Hormone Therapy ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Locally Advanced Prostate Cancer ◽

Preliminary Results

Download Full-text

Chromatin relaxation is a feature of advanced prostate cancer

Endocrine Abstracts ◽

10.1530/endoabs.42.oc9 ◽

2016 ◽

Author(s):

Alfonso Urbanucci ◽

Stefan Barfeld ◽

Ville Kytola ◽

Daniel Vodak ◽

Liisa Sjoblom ◽

...

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Chromatin Relaxation

Download Full-text

Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy

Minerva Urologica e Nefrologica ◽

10.23736/s0393-2249.19.03388-5 ◽

2019 ◽

Vol 71 (5) ◽

Cited By ~ 2

Author(s):

Fabio Zattoni ◽

Alessandro Morlacco ◽

Fabio Matrone ◽

Mauro Arcicasa ◽

Lorenzo Buttazzi ◽

...

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Multimodal Treatment ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Extended Lymphadenectomy ◽

Locally Advanced Prostate Cancer

Download Full-text

A Parallel Arm Phase 1b/2a Study of DKN-01 as Monotherapy or in Combination With Docetaxel for the Treatment of Advanced Prostate Cancer With Elevated DKK1

Case Medical Research ◽

10.31525/ct1-nct03837353 ◽

2000 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Phase 1B

Download Full-text

Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate Cancer

Case Medical Research ◽

10.31525/ct1-nct04093375 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Radical Prostatectomy ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Radical Radiotherapy ◽

Locally Advanced Prostate Cancer

Download Full-text

Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomy

Case Medical Research ◽

10.31525/ct1-nct04295447 ◽

2020 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

High Risk ◽

Radical Prostatectomy ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Locally Advanced Prostate Cancer

Download Full-text

Faculty Opinions recommendation of Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1123037.580149 ◽

2008 ◽

Author(s):

Derek Raghavan

Keyword(s):

Prostate Cancer ◽

Advanced Prostate Cancer ◽

Locally Advanced ◽

Locally Advanced Prostate Cancer

Download Full-text

Faculty Opinions recommendation of Efficacy of a second line luteinizing hormone-releasing hormone agonist after advanced prostate cancer biochemical recurrence.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14267095.15779304 ◽

2012 ◽

Author(s):

Hendrik van Poppel ◽

Yuri Tolkach

Keyword(s):

Prostate Cancer ◽

Luteinizing Hormone ◽

Biochemical Recurrence ◽

Advanced Prostate Cancer ◽

Second Line ◽

Luteinizing Hormone Releasing Hormone ◽

Releasing Hormone

Download Full-text